Page 106 - JSOM Spring 2020

10. Friedl KE, Moore RJ, Hoyt RW, et al. Endocrine markers of 29. Friedl KE, Dettori JR, Hannan CJ Jr, et al. Comparison of the ef-
semistarvation in healthy lean men in a multistressor environ- fects of high dose testosterone and 19-nortestosterone to a replace-
ment. J Appl Physiol (1985). 2000;88(5):1820–30. ment dose of testosterone on strength and body composition in
11. Linderman JK, Laubach LL. Energy balance during 24 hours of normal men. J Steroid Biochem Mol Biol. 1991;40(4–6):607–612.
treadmill running. J Exerc Physiol Online. 2004;7(2):37. 30. Giorgi A, Weatherby RP, Murphy PW. Muscular strength, body
12. Roberts AC, McClure RD, Weiner RI, et al. Overtraining affects composition and health response to the use of testosterone enan-
male reproductive status. Fertil Steril. 1993;60(4):686–692. thate: a double blind study. J Sci Med Sport. 1999;2(4):341–355.
13. Röjdmark S. Influence of short-term fasting on the pituitary- 31. Bhasin S, Storer TW, Berman N, et al. The effects of supraphysio-
testicular axis in normal men. Horm Res. 1987;25(3):140–146. logic doses of testosterone on muscle size and strength in normal
14. Leproult R, Van Cauter E. Effect of 1 week of sleep restriction men. N Engl J Med. 1996;335(1):1–7.
on testosterone levels in young healthy men. JAMA. 2011;305 32. Freed DL, Banks AJ, Longson D, et al. Anabolic steroids in ath-
(21):2173–2174. letics: crossover double-blind trial on weightlifters. Br Med J.
15. Mooradian AD, Morley JE, Korenman SG. Biological actions of 1975;2(5969):471–473.
androgens. Endocr Rev. 1987;8(1):1–28. 33. Hervey GR, Knibbs AV, Burkinshaw L, et al. Effects of methan-
16. Lin GC, Erinoff L, editors. Anabolic Steroid Abuse. Rockville, dienone on the performance and body composition of men un-
MD: National Institute on Drug Abuse; 1990:97. Research Mono- dergoing athletic training. Clin Sci (Lond). 1981;60(4):457–461.
graph 102. 34. Hervey GR, Hutchinson I, Knibbs AV, et al. “Anabolic” effects
17. Southren AL, Tochimoto S, Carmody NC, et al. Plasma produc- of methandienone in men undergoing athlete training. Lancet.
tion rates of testosterone in normal adult men and women and in 1976;2(7988):699–702.
patients with the syndrome of feminizing testes. J Clin Endocrinol 35. Gold J, Batterham MJ, Rekers H, et al. Effects of nandrolone
Metab. 1965;25(11):1441–1450. decanoate compared with placebo or testosterone on HIV-associ-
18. Margo K, Winn R. Testosterone treatments: why, when, and ated wasting. HIV Med. 2006;7(3):146–155.
how? Am Fam Physician. 2006;73(9):1591–1598. 36. Knapp PE, Storer TW, Herbst KL, et al. Effects of a supraphysi-
19. Kido Y, Sakazume S, Abe Y, et al. Testosterone replacement ological dose of testosterone on physical function, muscle perfor-
therapy to improve secondary sexual characteristics and body mance, mood, and fatigue in men with HIV-associated weight loss.
composition without adverse behavioral problems in adult male Am J Physiol Endocrinol Metab. 2008;294(6):E1135–E1143.
patients with Prader-Willi syndrome: an observational study. Am 37. Grunfeld C, Kotler DP, Dobs A, et al. Oxandrolone in the treat-
J Med Genet A. 2013;161A(9):2167–2173. ment of HIV-associated weight loss in men: a randomized, dou-
20. Kenny AM, Prestwood KM, Gruman CA, et al. Effects of trans- ble-blind, placebo-controlled study. J Acquir Immune Defic Syndr.
dermal testosterone on bone and muscle in older men with 2006;41(3):304–314.
low bioavailable testosterone levels. J Gerontol. 2001;56A(5): 38. Hengge UR, Stocks K, Weihler H, et al. Double-blind, random-
M266–M272. ized, placebo-controlled phase III trial of oxymetholone for treat-
21. Kenny AM, Kleppinger A, Annis K, et al. Effects of transdermal ment of HIV wasting. AIDS. 2003;17(5):699–710.
testosterone on bone and muscle in older men with low bioavail- 39. Ferreira IM, Verreschi IT, Nery LE, et al. The influence of 6 months
able testosterone levels, low bone mass, and physical frailty. J Am of oral anabolic steroids on body mass and respiratory muscles in
Geriatr Soc. 2010;58(6):1134–1143. undernourished COPD patients. Chest. 1998;114(1):19–28.
22. Hildreth KL, Barry DW, Moreau KL, et al. Effects of testosterone 40. Casaburi R, Bhasin S, Cosentino L, et al. Effects of testosterone
and progressive resistance exercise in healthy, highly functioning and resistance training in men with chronic obstructive pulmo-
older men with low-normal testosterone levels. J Clin Endocrinol nary disease. Am J Respir Crit Care Med. 2004;170(8):870–878.
Metab. 2013;98(5):1891–1900. 41. Johansen KL, Painter PL, Sakkas GK, et al. Effects of resistance
23. Urban RJ, Bodenburg YH, Gilkison C, et al. Testosterone ad- exercise training and nandrolone decanoate on body composi-
ministration to elderly men increases skeletal muscle strength and tion and muscle function among patients who receive hemodial-
protein synthesis. Am J Physiol. 1995;269(5 Pt 1):E820–E826. ysis: a randomized, controlled trial. J Am Soc Nephrol. 2006;17
24. Bhasin S, Woodhouse L, Casaburi R, et al. Testosterone dose- (8):2307–2314.
response relationships in healthy young men. Am J Physiol Endo- 42. Pescatello LS, Arena R, Riebe D, Thomas PD, editors. ACSM’s
crinol Metab. 2001;281(6):E1172–E1181. Guidelines for Exercise Testing and Prescriptions. 9th ed. Phila-
25. Forbes GB, Porta CR, Herr BE, et al. Sequence of changes in body delphia, PA: Lippincott Williams & Wilkins; 2014:88–93.
composition induced by testosterone and reversal of changes after 43. Johnson WO, Moore K. The loser. Sports Illustrated, 1988;Oct
drug is stopped. JAMA. 1992;267(3):397–399. 3:20–27.
26. Griggs RC, Kingston W, Jozefowicz RF, et al. Effect of testoster- 44. Anabolic Steroids Control Act, H.R. 4658, 103rd Cong. (1990).
one on muscle mass and muscle protein synthesis. J Appl Physiol. 45. Fudala PJ, Weinrieb RM, Calarco JS, et al. An evaluation of an-
(1985) 1989;66(1):498–503. abolic-androgenic steroid abusers over a period of 1 year: seven
27. Frederiksen L, Højlund K, Hougaard DM, et al. Testosterone case studies. Ann Clin Psychiatry. 2003;15(2):121–130.
therapy increased muscle mass and lipid oxidation in aging men. 46. Bassil N, Alkaade S, Morley JE. Ther Clin Risk Manag. 2009;
Age (Dordr). 2012;34(1):145–156. 5(3):427–448. Epub 2009 Jun 22.
28. Alén M, Häkkinen K. Androgenic steroid effects on serum hor-
mones and on maximal force development in strength athletes. J
Sports Med Phys Fitness. 1987;27(1):38–46.

100 | JSOM Volume 20, Edition 1 / Spring 2020